Updated: Oct 31, 2024
The average Rapport Therapeutics stock price target is 38.50 with a max estimate of 42.00 and a min estimate of 35.00
Review Rapport Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Oct 31, 2024
No Data